Antiprotozoal activity of 1-phenethyl-4-aminopiperidine derivatives

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 3815-3821

  Dardonville, Christophe ^a   Fernández Fernández, Cristina ^a   Gibbons, Sarah Louise ^a   Jagerovic, Nadine ^a   Nieto, Lidia ^a   Ryan, Gary ^a   Kaiser, Marcel ^b   Brun, Reto ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENETHYL 4 AMINOPIPERIDINE DERIVATIVE; ANTIPROTOZOAL AGENT; BENZNIDAZOLE; BISAMIDINE DERIVATIVE; BISGUANIDINE DERIVATIVE; CHLOROQUINE; MELARSOPROL; PYRIMETHAMINE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RAT; TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; FEMALE; INHIBITORY CONCENTRATION 50; LEISHMANIA DONOVANI; MICE; MOLECULAR STRUCTURE; PARASITIC SENSITIVITY TESTS; PIPERIDINES; PLASMODIUM FALCIPARUM; PROTOZOA; RATS; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CRUZI;

EID: 70349083353     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00124-09     Document Type: Article

References (43)

1. Ancelin, M. L., M. Calas, A. Bonhoure, S. Herbute, and H. J. Vial. 2003. In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism. Antimicrob. Agents Chemother. 47:2598-2605.
2. Ancelin, M. L., M. Calas, V. Vidal-Sailhan, S. Herbute, P. Ringwald, and H. J. Vial. 2003. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob. Agents Chemother. 47:2590-2597.
3. Augustyns, K., K. Amssoms, A. Yamani, P. K. Rajan, and A. Haemers. 2001. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents. Curr. Pharm. Des. 7:1117-1141.
4. Baltz, T., D. Baltz, C. Giroud, and J. Crockett. 1985. Cultivation in a semidefined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 4:1273-1277.
5. Bellevue, F. H., III, M. Boahbedason, R. Wu, P. M. Woster, J. Casero, A. Robert, D. Rattendi, S. Lane, and C. J. Bacchi. 1996. Structural comparison of alkylpolyamine analogues with potent in vitro antitumor or antiparasitic activity. Bioorg. Med. Chem. Lett. 6:2765-2770.
6. Biagini, G. A., E. M. Pasini, R. Hughes, H. P. De Koning, H. J. Vial, P. M. O'Neill, S. A. Ward, and P. G. Bray. 2004. Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 104:3372-3377.
7. Bitonti, A. J., J. A. Dumont, T. L. Bush, M. L. Edwards, D. M. Stemerick, P. P. McCann, and A. Sjoerdsma. 1989. Bis(benzyl)polyamine analogs inhibit the growth of chloroquine-resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with alpha-difluoromethylornithine cure murine malaria. Proc. Natl. Acad. Sci. USA 86:651-655.
8. Brinner, K. M., J. Mi Kim, H. Habashita, I. Y. Gluzman, D. E. Goldberg, and J. A. Ellman. 2002. Novel and potent anti-malarial agents. Bioorg. Med. Chem. 10:3649-3661.
9. Brinner, K. M., M. A. Powles, D. M. Schmatz, and J. A. Ellman. 2005. Potent 4-aminopiperidine based antimalarial agents. Bioorg. Med. Chem. Lett. 15:345-348.
10. Buckner, F. S., C. L. Verlinde, A. C. La Flamme, and W. C. Van Voorhis. 1996. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob. Agents Chemother. 40:2592-2597.
11. Calas, M., M. Ouattara, G. Piquet, Z. Ziora, Y. Bordat, M. L. Ancelin, R. Escale, and H. Vial. 2007. Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines. J. Med. Chem. 50:6307-6315.
12. Comini, M. A., S. A. Guerrero, S. Haile, U. Menge, H. Lünsdorf, and L. Flohé. 2004. Validation of Trypanosoma brucei trypanothione synthetase as drug target. Free Radic. Biol. Med. 36:1289-1302.
13. Croft, S., J. Urbina, and R. Brun. 1997. Chemotherapy of human leishmaniasis and trypanosomiasis, p. 245-257. In G. Hide, J. C. Mottram, G. H. Coombs, and P. H. Holmes (ed.), Trypanosomiasis and leishmaniasis: biology and control. CAB International, Oxon, United Kingdom.
14. Cunningham, I. 1977. New culture medium for maintenance of tsetse tissues and growth of trypanosomatids. J. Protozool. 24:325-329. (Pubitemid 8156212)
15. Dardonville, C. 2005. Recent advances in antitrypanosomal chemotherapy: patent literature 2002-2004. Expert Opin. Ther. Patents 15:1241-1257.
16. Dardonville, C., M. P. Barrett, R. Brun, M. Kaiser, F. Tanious, and W. D. Wilson. 2006. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity. J. Med. Chem. 49:3748-3752.
17. Dardonville, C., and R. Brun. 2004. Bisguanidine, bis(2-aminoimidazoline) , and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. Synthesis and in vitro evaluation. J. Med. Chem. 47:2296-2307.
18. 2-imidazoline binding sites. Bioorg Med. Chem. 14:6570-6580.
19. 2-imidazoline binding sites. Bioorg Med. Chem. Lett. 14:491-493.
20. 2-imidazoline binding site affinity of a structurally different type of ligands. Bioorg. Med. Chem. 10:1525-1533.
21. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
22. Edwards, M. L., D. M. Stemerick, A. J. Bitonti, J. A. Dumont, P. P. McCann, P. Bey, and A. Sjoerdsma. 1991. Antimalarial polyamine analogs. J. Med. Chem. 34:569-574.
23. Fairlamb, A. H., and A. Cerami. 1992. Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46:695-729.
24. Franke-Fayard, B., H. Trueman, J. Ramesar, J. Mendoza, M. van der Keur, R. van der Linden, R. E. Sinden, A. P. Waters, and C. J. Janse. 2004. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 137:23-33.
25. Heby, O., L. Persson, and M. Rentala. 2007. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Amino Acids 33:359-366. (Pubitemid 47222983)
26. Heby, O., S. C. Roberts, and B. Ullman. 2003. Polyamine biosynthetic enzymes as drug targets in parasitic protozoa. Biochem. Soc. Trans. 31:415-419.
27. Kumar, S., M. Guha, V. Choubey, P. Maity, and U. Bandyopadhyay. 2007. Antimalarial drugs inhibiting hemozoin (β-hematin) formation: a mechanistic update. Life Sci. 80:813-828. (Pubitemid 46149853)
28. Martyn, D. C., D. C. Jones, A. H. Fairlamb, and J. Clardy. 2007. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. Bioorg Med. Chem. Lett. 17:1280-1283.
29. Matile, H., and J. R. L. Pink. 1990. Plasmodium falciparum malaria parasite cultures and their use in immunology, p. 221. In I. Lefkovits and B. Pernis (ed.), Immunological methods. Academic Press, San Diego, CA.
30. Mikus, J., and D. Steverding. 2000. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol. Int. 48:265-269.
31. Müller, S., G. H. Coombs, and R. D. Walter. 2001. Targeting polyamines of parasitic protozoa in chemotherapy. Trends Parasitol. 17:242-249. (Pubitemid 32422170)
32. Nwaka, S., and A. Hudson. 2006. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov. 5:941-955.
33. Orenes Lorente, S., R. Gomez, C. Jimenez, S. Cammerer, V. Yardley, K. de Luca-Fradley, S. L. Croft, L. M. Ruiz Perez, J. Urbina, D. Gonzalez Pacanowska, and I. H. Gilbert. 2005. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa. Bioorg. Med. Chem. 13:3519-3529.
34. Peters, W. 1987. Chemotherapy and drug resistance in malaria, vol.1. Academic Press, London, United Kingdom.
35. Raz, B., M. Iten, Y. Grether-Buhler, R. Kaminsky, and R. Brun. 1997. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop. 68:139-147. (Pubitemid 27438330)
36. Reguera, R. M., B. L. Tekwani, and R. Balana-Fouce. 2005. Polyamine transport in parasites: a potential target for new antiparasitic drug development. Comp. Biochem. Physiol. C 140:151-164.
37. Renslo, A. R., and J. H. McKerrow. 2006. Drug discovery and development for neglected parasitic diseases. Nat. Chem. Biol. 2:701-710.
38. Rodríguez, F., I. Rozas, M. Kaiser, R. Brun, B. Nguyen, W. D. Wilson, R. N. García, and C. Dardonville. 2008. New bis(2- aminoimidazoline) and bisguanidine DNA minor groove binders with potent in vivo antitrypanosomal and antiplasmodial activity. J. Med. Chem. 51:909-923.
39. Schmidt, A., and R. L. Krauth-Siegel. 2002. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development. Curr. Top. Med. Chem. 2:1239-1259.
40. Special Programme for Research and Training in Tropical Diseases (TDR). November 2008. Novo nordisk licences compound library to TDR-supported researchers. TDRnews 2008(18):6. http://apps.who.int/tdr/publications/tdrnews/ pdf/TDRnews-issue-81.pdf.
41. Thaithong, S., G. H. Beale, and M. Chutmongkonkul. 1983. Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand. Trans. R. Soc. Trop. Med. Hyg. 77:228-231.
42. Thuita, J. K., S. M. Karanja, T. Wenzler, R. E. Mdachi, J. M. Ngotho, J. M. Kagira, R. Tidwell, and R. Brun. 2008. Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis. Acta Trop. 108:6-10.
43. Zou, Y., Z. Wu, N. Sirisoma, P. M. Woster, R. A. Casero, Jr., L. M. Weiss, D. Rattendi, S. Lane, and C. J. Bacchi. 2001. Novel alkylpolyamine analogues that possess both antitrypanosomal and antimicrosporidial activity. Bioorg. Med. Chem. Lett. 11:1613-1617.